WT1 is constitutively expressed in AML, CML, and MDS as well as in solid tumors such as breast cancer, and WT1+CTLs have been identified in peripheral blood of patients. This evidence concerns the gene WT1 and chronic myelogenous leukemia, BCR-ABL1 positive.